COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S – Share repurchase programme

24/06/2019 - 14:47

Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 24 June 2019 – On 7 May 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European [...]

MyoKardia Publishes Data in Nature Digital Medicine Showing Potential of Wrist-Worn Biosensor to Screen for Hypertrophic Cardiomyopathy

24/06/2019 - 14:30

Continuous Monitoring with Wearable Device Detected Distinct Pulse Wave Patterns in Obstructive Hypertrophic Cardiomyopathy Patients as Compared to Healthy Volunteers SOUTH SAN FRANCISCO, Calif., June 24, 2019 (GLOBE [...]

Independent Readers Using Progenics’ PSMA AI Demonstrated a Statistically Significant Improvement of Accuracy, Speed, and Reproducibility Over Readers Without PSMA AI

24/06/2019 - 14:30

Oral Presentation of Progenics’ PSMA AI Technology at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2019 Annual Meeting NEW YORK, June 24, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ [...]

Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Highlight Unique Aspects of the Company’s GRAIN Technology Platform to Identify Novel Traits for Crops at the 3rd Precision CRISPR & NBT AgBio Congress

24/06/2019 - 14:30

WOBURN, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]

Bariatric Medical Institute of Texas Presents Favorable Study Results for Obalon Balloon Administration Using Navigation Device and Touch Dispenser

24/06/2019 - 14:30

New clinical data highlight convenience, efficiency, and safety of Obalon’s proprietary Navigation and Touch Dispenser systems to achieve reliable balloon administration without the use of x-ray SAN DIEGO, June 24, 2019 [...]

Generex Investor Conference Call Recording Now Available Online Detailing 1:1 Stock Dividend, Merger for NuGenerex Immuno-Oncology and Go Forward Plans

24/06/2019 - 14:30

MIRAMAR, Fla., June 24, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced the audio recording of its investor [...]

Novelion Therapeutics Responds to Whitefort Capital Petition

24/06/2019 - 14:30

VANCOUVER, British Columbia, June 24, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2019 After Market Close on June 27, 2019

24/06/2019 - 14:05

TUSTIN, Calif., June 24, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by providing [...]

Celldex Therapeutics Appoints Diane C. Young, M.D. as Senior Vice President, Chief Medical Officer

24/06/2019 - 14:01

HAMPTON, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced the appointment of Diane C. Young, M.D., as Senior Vice President, Chief Medical Officer, effective July 8, 2019 [...]

Nationally Recognized Medical Experts Join Receptor Life Science’s Scientific Advisory Board to Guide the Development of New Cannabinoid Therapies

24/06/2019 - 14:00

SEATTLE, June 24, 2019 (GLOBE NEWSWIRE) -- Receptor Life Sciences (RLS), a leader in FDA-regulated cannabinoid medicine drug development using proprietary delivery technologies, today announced the formation of its [...]

electroCore Announces gammaCore(TM) Listing on the NHS Supply Chain Catalogue

24/06/2019 - 14:00

LONDON, and BASKING RIDGE, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that gammaCore TM , the company’s [...]

Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial (“GEM-2 study”) of KB103 and Receives Regenerative Medicine Advanced Therapy (“RMAT”) Designation from FDA for KB103

24/06/2019 - 14:00

Safety data from all patients show that KB103 was well tolerated with no adverse events reported Five out of six wounds treated with KB103 in the Phase 2 trial closed 100% during the trial The average time to complete [...]

Dova Pharmaceuticals Announces Four Presentations on Avatrombopag in Patients with Chronic Immune Thrombocytopenia at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress

24/06/2019 - 14:00

DURHAM, N.C., June 24, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced the Company will present four abstracts with data from studies of avatrombopag in patients with chronic immune [...]

Medovex’s Transition to H-CYTE Underscores Biotechnology Focus

24/06/2019 - 14:00

Announces Long-Term Agreement to Launch a Promising New Cellular Treatment for COPD ALPHARETTA, Ga., June 24, 2019 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: Symbol MDVX) ("Medovex" or the "Company"), is transitioning to [...]

BioDelivery Sciences Expands Upon Report from Pain Management Task Force

24/06/2019 - 14:00

Company’s Activities Support Buprenorphine Recommendations Including: Primary Use of Buprenorphine in Chronic Pain when Clinically Indicated Having Payers Provide Coverage and Reimbursement for Buprenorphine for Chronic [...]

Entasis Therapeutics Appoints David Meek as Chairman of the Board

24/06/2019 - 14:00

WALTHAM, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]

Progenics Pharmaceuticals Files Supplemental Investor Presentation Rebutting Velan’s Latest Inaccurate Claims

24/06/2019 - 14:00

Board has Positioned Progenics to Maximize Value as a Result of Proactive and Deliberate Strategy Velan’s Baseless Criticisms about the Development of AZEDRA and 1095 Reveal a Fundamental Lack of Understanding of [...]

Blueberries Announces Appointment of Chief Financial Officer

24/06/2019 - 13:30

TORONTO, June 24, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. ( CSE: BBM ) (OTCQB: BBRRF) (FRA: 1OA) (" Blueberries " or the " Company "), a leading Latin American licensed producer of medicinal cannabis and [...]

Minerva Neurosciences Announces Achievement of Primary and Key Secondary Objectives in Phase 2b Clinical Trial of Seltorexant (MIN-202) in Insomnia

24/06/2019 - 13:30

Primary endpoint, defined as Latency to Persistent Sleep (LPS) at Night 1, showed improvement with a p-value ≤0.001 after treatment with 10 and 20 mg doses of seltorexant Key secondary endpoint, defined as Wake After [...]